ARTICLE | Company News
SuperGen, Barr Laboratories Inc. deal
July 29, 1996 7:00 AM UTC
SUPG acquired non-exclusive rights from Barr to market three generic anticancer products. The products are oral formulations of methotrexate, megestrol acetate and calcium leucovorin. Barr will manufa...